Monday, October 15, 2007

2006 - F.D.A. Dismisses Medical Benefit From Marijuana

This article, published on April 2006 in The New York Times, presents the reader with the ongoing battle between politics and science regarding the medical benefits and legalization of marijuana in the United States. In 2006 the FDA announced its dismissal of any medical benefits stemming from Marijuana use, a decision that might have been shaped by societal pressures and manipulations by opponents of medical marijuana use on the FDA. Opinions on this subject are constantly being adapted to politician’s interests and beliefs by the use of legislation. The FDA’s viewpoints seem to stem more from political ideologies than from scientific data.

The FDA’s statement clearly contradicts the opinions of highly regarded scientists who believe in the positive effects of marijuana use for some patients. There is currently a dangerous reluctance from the part of the federal government to acknowledge the benefits of medical marijuana. Research on the subject is discouraged; studies proving marijuana’s benefits on certain diseases are never published. Statements without proof, such as marijuana being a gateway drug, are often used to discourage and attack this field of research. The federal government dismisses the opinions of prestigious medical institutes; ignorance stems from their desire to keep their attention away from controversial issues.

This article shows the unreliability of viewpoints given by any side regarding the legalization and medical benefits from marijuana use. We must be aware that most of the information regarding this subject is shaped by personal interests and might not be legitimate. Consequently, we must be skeptical whenever we read anything regarding the use of marijuana as medicinal therapy. Although in this article, it is made clear that in the medical community there is unanimous agreement on the advantageous effects of marijuana as medical therapy.


No comments: